Fellow, Advanced Heart Failure at Duke University
As of 2025 · Last known relationship
Joseph Buckley Lerman matters for linking advanced heart-failure care with research on heart transplantation, donor-heart preservation, and outcomes. At Duke, he is an Assistant Professor of Medicine, a member of the Duke Clinical Research Institute, and an Advanced Heart Failure and Transplant Cardiologist. His research examines outcomes and interventions in advanced heart failure and heart transplantation, including donor type, organ preservation, graft dysfunction, LVAD-related issues, and follow-up in pragmatic trials. His Duke training included internal medicine residency, cardiovascular medicine and advanced heart-failure fellowships, and clinical research fellowship. Earlier, he was an NIH T-32-funded DCRI research fellow and spent one year at NHLBI through the NIH Medical Research Scholar’s program conducting clinical and translational cardiovascular research. He earned an M.D. from Icahn School of Medicine at Mount Sinai and a B.A. from Brown University.
Each topic is linked to its supporting source in Sources.
Training includes Fellow, Advanced Heart Failure at Duke University, Fellow, Clinical Research at Duke University, Chief Fellow, Cardiovascular Medicine, and Fellow, Cardiovascular Medicine at Duke University, plus 10 more records.
Explore education and trainingAs of 2025
As of 2025
As of 2024
As of 2023
As of 2020
As of 2020
As of 2017
As of 2011
As of 2023
Awarded a Novo Nordisk grant for a phase 2 study of CDR132L in heart failure with preserved ejection fraction and left ventricular hypertrophy[8]
2026 to 2029
Publication: Between withdrawal and death: Can machine learning improve donation after circulatory death utilization?[8]
From 2026
Publication: Coronary Evaluation of Donor Hearts in the Donation After Circulatory Death Era[8]
From 2026
Publication: Donor Type and Organ Preservation in Heart Transplantation: Association with Recovery Following Severe Primary Graft Dysfunction[8]
From 2026
Publication: Impact of HeartMate 3 left ventricular assist device infection on outcomes following heart transplant[8]
From 2026
Publication: Lost to Follow-Up in Pragmatic Trials With Remote Follow-Up: Insights From CONNECT-HF and TRANSFORM-HF[8]
From 2026
Publication: Organ-specific differences in the epidemiology of cytomegalovirus infections in high-risk solid organ transplant recipients with prolonged follow-up: A 10-year experience[8]
From 2026
Publication: Outcomes Following HeartMate 3 Left Ventricular Assist Device (LVAD) Exchange for Complex LVAD-Specific Infection[8]
From 2026
Publication: Out-of-Sequence Donor Heart Allocation: A United Network for Organ Sharing Registry Analysis[8]
From 2026
Publication: Prognostic implications of the updated ISHLT definition for severe graft dysfunction: An analysis from the International PGD Consortium and UNOS Databases[8]
From 2026
Publication: Short-term heart transplant outcomes with heart organ procurement services[8]
From 2026
Research on outcomes and interventions in patients with advanced heart failure and heart transplants[8]